|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.74 EUR | +1.27% |
|
-0.38% | -1.65% |
| 06:45am | DIARY - Italy to March 31 | RE |
| Feb. 03 | Recordati Buys Back Over EUR3 Million in Own Shares | AN |
Business description: Recordati
- pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (35.6%).
Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).
Number of employees: 4,539
Sales by Activity: Recordati
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Specialty & Primary Care | 1.13B | 1.2B | 1.26B | 1.37B | 1.51B |
Pharmaceutical Sector for Rare Diseases | 319M | 384M | 596M | 715M | 834M |
Geographical breakdown of sales: Recordati
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
United States of America | 128M | 182M | 268M | 323M | 396M |
Italy | 271M | 263M | 275M | 313M | 333M |
Other International | 201M | 204M | 229M | 266M | 283M |
Spain | 83.82M | 120M | 143M | 165M | 214M |
France | 144M | 152M | 169M | 180M | 175M |
Other Eastern European | 91.98M | 112M | 129M | 150M | 168M |
Other Western European | 91.12M | 104M | 137M | 152M | 164M |
Germany | 136M | 153M | 168M | 151M | 161M |
Russia, Other CIS Countries and Ukraine | 100M | 99.6M | 132M | 141M | 151M |
Turkey | 79.19M | 70.31M | 74.34M | 97.52M | 133M |
Portugal | 42.72M | 45.43M | 53.46M | 60.2M | 67.18M |
North Africa | 41.25M | 35.9M | 37.66M | 40.22M | 45.74M |
Asia and Oceania | - | - | - | - | 27.91M |
Europe Excluding Italy | 15.24M | 17.14M | 14.35M | 15.21M | 16.34M |
America (U.S.A. Excluded) | 4.58M | 4.76M | 4.72M | 5.54M | 6.01M |
Africa | 1.5M | 1.68M | 2.58M | 1.33M | 601K |
Australasia | 16.88M | 14.52M | 16.99M | 21.53M | - |
Executive Committee: Recordati
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 63 | 2021-11-30 |
Milan Zdravkovic
CTO | Chief Tech/Sci/R&D Officer | 56 | 2023-09-30 |
Giovanni Minora
CMP | Compliance Officer | - | 2006-12-31 |
Eugenia Litz
IRC | Investor Relations Contact | - | 2023-12-31 |
| General Counsel | - | 2023-03-31 |
Composition of the Board of Directors: Recordati
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Recordati
CHM | Chairman | 54 | 2021-11-30 |
Giampiero Mazza
CHM | Chairman | 56 | 2018-06-11 |
Cathrin Petty
BRD | Director/Board Member | 52 | 2018-06-11 |
| Director/Board Member | 62 | 2019-02-04 | |
| Director/Board Member | 57 | 2020-04-28 | |
Robert Koremans
BRD | Director/Board Member | 63 | - |
Kim Stratton
BRD | Director/Board Member | 64 | 2021-12-15 |
Stephen Sands
BRD | Director/Board Member | 69 | - |
Diva Moriani
BRD | Director/Board Member | 57 | - |
Holdings: Recordati
| Name | Equities | % | Valuation |
|---|---|---|---|
RECORDATI 1.5% | 3,130,654 | 1.5% | 173 M $ |
PURETECH HEALTH PLC 3.96% | 9,559,540 | 3.96% | 17 M $ |
Company details: Recordati
Group companies: Recordati
| Name | Category and Sector |
|---|---|
Herbacos Recordati sro
 Herbacos Recordati sro Manufactures and distributes cosmetic products | |
Herbacos Recordati sro
Herbacos Recordati sro Manufactures and distributes cosmetic products | |
Recordati AG
 Recordati AG Provides pharmaceutical services | |
Recordati AG
Recordati AG Provides pharmaceutical services | |
Recordati Ireland Ltd.
 Recordati Ireland Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products |
Pharmaceuticals: Major
|
Other Pharmaceuticals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | -0.17% | -18.22% | +18.86% | 11.48B | |
| -1.28% | +0.05% | +18.94% | +205.65% | 935B | |
| -0.56% | +3.42% | +55.85% | +47.86% | 575B | |
| -0.08% | -1.05% | +17.14% | +50.14% | 395B | |
| -0.03% | +0.54% | +21.95% | +26.50% | 368B | |
| -3.51% | +3.78% | +34.80% | +10.24% | 292B | |
| +0.93% | +1.27% | +19.41% | +22.84% | 294B | |
| +0.54% | +3.44% | +24.72% | +51.56% | 299B | |
| +0.62% | -14.52% | -48.91% | -35.07% | 220B | |
| -2.21% | +9.03% | +28.03% | +56.59% | 202B | |
| Average | +0.71% | +1.46% | +15.37% | +45.52% | 359.18B | |
| Weighted average by Cap. | +0.86% | +2.09% | +23.00% | +77.53% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REC Stock
- Company Recordati
Select your edition
All financial news and data tailored to specific country editions
